Annual Report

Overview

The report presents Sudarshan Pharma Industries Limited's 15th Annual Report for FY2022-23, covering consolidated revenue from operations of 46,133.19 INR lakhs and consolidated profit for the year of 703.67 INR lakhs. It records the successful SME IPO and BSE listing during the year. The company also reports CSR support for a housing project and CSR spending of ₹ 8.50 Lakhs during the financial year.

Document

Report type: Annual Report
Class: Financial
Scope: Full report
Fiscal year: 2022-2023
Period: 1 April 2022 – 31 March 2023
Language: English
Pages
File size

Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services